AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32769863 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body training (MBT)
Number of subjects: 56
Study 34966524 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-computer interface-operated lower limb rehabilitation robot (BCI-LLRR)
Number of subjects: 0
Study 34966524 — intervention group
Group type: COMPARATOR
Intervention: Lower limb pedal training (control group)
Number of subjects: 0
Study 32223340 — intervention group
Group type: EXPERIMENTAL
Intervention: Free 1-month membership to Kansas City's bike share system, B-cycle
Number of subjects: 56
Study 32223340 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bike share membership)
Number of subjects: 56
Study 35859473 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied to one socket after tooth extraction
Number of subjects: 30
Study 35859473 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRF applied)
Number of subjects: 30
Study 34521594 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored nutrition interventions based on individual nutrition literacy levels
Number of subjects: 0
Study 34521594 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard intervention)
Number of subjects: 0
Study 34521594 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored nutrition interventions
Number of subjects: 0
Study 35333599 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 882
Study 35333599 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab-chemotherapy
Number of subjects: 882
Study 34301983 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 25
Study 34301983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 33142490 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% AJN extract
Number of subjects: 720
Study 33142490 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% AJN extract
Number of subjects: 720
Study 33142490 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% AJN extract
Number of subjects: 720
Study 32167402 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent group training tailored to the special needs of foster families
Number of subjects: 81
Study 32167402 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 81
Study 34090794 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB angioplasty
Number of subjects: 1009
Study 34090794 — intervention group
Group type: COMPARATOR
Intervention: PTA
Number of subjects: 1009
Study 34292050 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress reappraisal
Number of subjects: 339
Study 34292050 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 339
Study 33795297 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly teriparatide injections (40 ?g/week)
Number of subjects: 80
Study 33795297 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 80
Study 36375191 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity ESWT (0.03 mJ/mm2)
Number of subjects: 69
Study 36375191 — intervention group
Group type: COMPARATOR
Intervention: Medium-Intensity ESWT (0.09 mJ/mm2)
Number of subjects: 69
Study 32961445 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus EP
Number of subjects: 521
Study 32961445 — intervention group
Group type: COMPARATOR
Intervention: EP
Number of subjects: 521
Study 34711071 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Support (IS)
Number of subjects: 48
Study 34711071 — intervention group
Group type: COMPARATOR
Intervention: Weekly follow-up meetings
Number of subjects: 48
Study 33588904 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS plus lifestyle modification
Number of subjects: 60
Study 33588904 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle modification alone
Number of subjects: 60
Study 35081273 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN-6 for extraction, discrimination, and detection
Number of subjects: 1016
Study 35081273 — intervention group
Group type: EXPERIMENTAL
Intervention: Mask R-CNN for segmentation
Number of subjects: 1016
Study 35081273 — intervention group
Group type: EXPERIMENTAL
Intervention: LeNet-5 for diagnosis and classification
Number of subjects: 1016
Study 35081273 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted models for diagnosis and classification
Number of subjects: 1016
Study 35081273 — intervention group
Group type: COMPARATOR
Intervention: Radiologists' subjective diagnoses
Number of subjects: 1016
Study 33612170 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity Band PLUS
Number of subjects: 488
Study 33341925 — intervention group
Group type: COMPARATOR
Intervention: Survey version A (no risk information provided)
Number of subjects: 293
Study 33341925 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey version B (risk information provided)
Number of subjects: 293
Study 33341925 — intervention group
Group type: COMPARATOR
Intervention: Survey version A and B (comparison)
Number of subjects: 293
Study 34162330 — intervention group
Group type: EXPERIMENTAL
Intervention: Extension position group (EP group)
Number of subjects: 75
Study 34162330 — intervention group
Group type: COMPARATOR
Intervention: Neutral position group (NP group)
Number of subjects: 75
Study 34162330 — intervention group
Group type: COMPARATOR
Intervention: Sniffing position group (SP group)
Number of subjects: 75
Study 34162330 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 75
Study 33512387 — intervention group
Group type: EXPERIMENTAL
Intervention: OMT-only group
Number of subjects: 36
Study 33512387 — intervention group
Group type: EXPERIMENTAL
Intervention: OMT + medication group
Number of subjects: 36
Study 33574872 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius SGL03
Number of subjects: 51
Study 33574872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 35761321 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP intervention (theory-based consultation skills training for pharmacy staff with environmental prompts)
Number of subjects: 1272
Study 35761321 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 1272
Study 35761321 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP intervention
Number of subjects: 1272
Study 35761321 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 1272
Study 32862437 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (3.5 µg/kg followed by 7 µg/kg/h) administered before ischaemia (preconditioning)
Number of subjects: 18
Study 32862437 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (3.5 µg/kg followed by 7 µg/kg/h) administered after beginning ischaemia (post-conditioning)
Number of subjects: 18
Study 32862437 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexmedetomidine)
Number of subjects: 18
Study 34320585 — intervention group
Group type: EXPERIMENTAL
Intervention: New method for anterior boundary demarcation of the nasopharynx
Number of subjects: 20
Study 34400865 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacy-based medication therapy management programme
Number of subjects: 0
Study 34400865 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35945604 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilucoplan
Number of subjects: 81
Study 35945604 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 81
Study 34290201 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective refraction (SR)
Number of subjects: 90
Study 34290201 — intervention group
Group type: EXPERIMENTAL
Intervention: Autorefraction (AR)
Number of subjects: 90
Study 34290201 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront aberrometry (WA)
Number of subjects: 90
Study 34290201 — intervention group
Group type: EXPERIMENTAL
Intervention: Autorefraction (AR) and Wavefront aberrometry (WA)
Number of subjects: 90
Study 34290201 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial least squares regression and random forest regression
Number of subjects: 90
Study 35562420 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 98
Study 35562420 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation among patients using calcium channel blockers
Number of subjects: 98
Study 33839443 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postoperative D-dimer levels
Number of subjects: 666
Study 35022728 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical training and activity promotion program (12-week intervention)
Number of subjects: 118
Study 35022728 — intervention group
Group type: COMPARATOR
Intervention: Unspecific motor placebo activity (control group)
Number of subjects: 118
Study 32633662 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 18
Study 32633662 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.05 mg/kg)
Number of subjects: 18
Study 36496466 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual frame (risk visualized)
Number of subjects: 0
Study 36496466 — intervention group
Group type: COMPARATOR
Intervention: Non-visual frame (risk not visualized)
Number of subjects: 0
Study 33463794 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week stretching intervention by physical therapists
Number of subjects: 124
Study 33463794 — intervention group
Group type: COMPARATOR
Intervention: Control group (without the intervention)
Number of subjects: 124
Study 36074457 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention through an informative manual
Number of subjects: 0
Study 36074457 — intervention group
Group type: COMPARATOR
Intervention: Routine information from the unit (Control)
Number of subjects: 0
Study 33876600 — intervention group
Group type: EXPERIMENTAL
Intervention: Three Source Capture-Recapture (3S-CRC)
Number of subjects: 958
Study 33876600 — intervention group
Group type: EXPERIMENTAL
Intervention: Successive Sampling Population Size Estimates (SS-PSE)
Number of subjects: 958
Study 36357340 — intervention group
Group type: EXPERIMENTAL
Intervention: Center+home‐based intervention
Number of subjects: 325
Study 36357340 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-based intervention
Number of subjects: 325
Study 36357340 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 325
Study 33485895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelipepimut-S (NPS) plus trastuzumab
Number of subjects: 99
Study 33485895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 36479561 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 598
Study 36479561 — intervention group
Group type: COMPARATOR
Intervention: Control (sham stimulus)
Number of subjects: 598
Study 33761180 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme plus a 16-week food education programme (EXP); n = 18, 15-minute group classes and dual-task strategies during exercise
Number of subjects: 33
Study 33761180 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise programme (CON); n = 15, combined exercise, three sessions per week, 75 minutes per session
Number of subjects: 33
Study 33746216 — intervention group
Group type: EXPERIMENTAL
Intervention: PUFAs supplementation (1000 mg daily)
Number of subjects: 38
Study 33493448 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin sodium 25,000 IU in 5 mL, administered every 6 hours for 10 days via nebuliser
Number of subjects: 256
Study 33493448 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin sodium 25,000 IU in 5 mL
Number of subjects: 256
Study 34065571 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) for 20 min with intermittent stimulation (4 s WB-EMS/4 s rest, at 85 Hz, 350 μs)
Number of subjects: 10
Study 34065571 — intervention group
Group type: COMPARATOR
Intervention: No WB-EMS after 4 weeks
Number of subjects: 10
Study 35112672 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory training with omega-3 supplementation
Number of subjects: 58
Study 35112672 — intervention group
Group type: COMPARATOR
Intervention: Olfactory training only (control group)
Number of subjects: 58
Study 34148172 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Neomycin and Bacitracin (OIVA group)
Number of subjects: 204
Study 34148172 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics (IVA group)
Number of subjects: 204
Study 34148172 — intervention group
Group type: EXPERIMENTAL
Intervention: OIVA with mechanical bowel preparation (MBP)
Number of subjects: 204
Study 34148172 — intervention group
Group type: COMPARATOR
Intervention: IVA with mechanical bowel preparation (MBP)
Number of subjects: 204
Study 35911419 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fasting
Number of subjects: 109
Study 35911419 — intervention group
Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 109
Study 34411060 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (20 ?g/kg)
Number of subjects: 20
Study 34544265 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 5258
Study 34544265 — intervention group
Group type: COMPARATOR
Intervention: Dutasteride
Number of subjects: 5258
Study 34544265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5258
Study 32824480 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis with PreforPro
Number of subjects: 68
Study 32824480 — intervention group
Group type: COMPARATOR
Intervention: Bifidobacterium animalis subsp. lactis
Number of subjects: 68
Study 35971297 — intervention group
Group type: EXPERIMENTAL
Intervention: Opium tincture (OT)
Number of subjects: 204
Study 35971297 — intervention group
Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 204
Study 33407773 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) plus needle retention (NR)
Number of subjects: 206
Study 33407773 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 206
Study 33407773 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EA + NR and EA)
Number of subjects: 206
Study 32427113 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly tailored text message and interactive voice response intervention for 12 weeks
Number of subjects: 135
Study 32427113 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 135
Study 32427113 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 135
Study 32427113 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study 32427113 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 135
Study 34031709 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bundle (SB) ACL reconstruction
Number of subjects: 65
Study 34031709 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) ACL reconstruction
Number of subjects: 65
Study 33735275 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (low frequency) - single incentive for absolute HbA1c reduction
Number of subjects: 60
Study 33735275 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (moderate frequency) - two-part incentive for home testing of glucose and absolute HbA1c reduction
Number of subjects: 60
Study 33735275 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (high frequency) - multiple component incentive for home testing, attendance of weekly telephone education classes and absolute HbA1c reduction
Number of subjects: 60
Study 34857404 — intervention group
Group type: EXPERIMENTAL
Intervention: VR simulator for K‐wire insertion in the distal radius
Number of subjects: 20
Study 34857404 — intervention group
Group type: COMPARATOR
Intervention: Standard teaching on cadavers
Number of subjects: 20
Study 32517513 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialogue-based intervention (8 individual 1-1½ hour sessions during the first six months post-stroke)
Number of subjects: 322
Study 32517513 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 322
Study 32517513 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialogue-based intervention
Number of subjects: 322
Study 35258025 — intervention group
Group type: EXPERIMENTAL
Intervention: Beach Tennis (BT) session
Number of subjects: 22
Study 35258025 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control session (Con)
Number of subjects: 22
Study 33160280 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) frequency
Number of subjects: 37392
Study 33160280 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports participation
Number of subjects: 37392
Study 33160280 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) frequency among children who participated in sports
Number of subjects: 37392
Study 35233748 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (60 mg) and Boswellic acids (200 mg) twice daily for 14 days
Number of subjects: 50
Study 35233748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 33984293 — intervention group
Group type: EXPERIMENTAL
Intervention: Mayo Clinic Care Transitions (MCCT) program (care management following nursing stay, including a home visit and nursing phone calls)
Number of subjects: 160
Study 33984293 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 160
Study 33984293 — intervention group
Group type: EXPERIMENTAL
Intervention: Mayo Clinic Care Transitions (MCCT) program
Number of subjects: 160
Study 32804205 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin 1000 U/kg every 48 hours for 6 doses, followed by 400 U/kg 3 times a week through postmenstrual age of 32 weeks.
Number of subjects: 941
Study 32804205 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham injections).
Number of subjects: 941
Study 35872394 — intervention group
Group type: EXPERIMENTAL
Intervention: Social networking group moderated by peer leaders with access to a static website offering RA materials
Number of subjects: 210
Study 35872394 — intervention group
Group type: COMPARATOR
Intervention: Control group with access only to the static website
Number of subjects: 210
Study 33760261 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Universal for Hand Use (Dentsply Sirona)
Number of subjects: 60
Study 33760261 — intervention group
Group type: EXPERIMENTAL
Intervention: HyFlex EDM (Coltene‐Whaledent)
Number of subjects: 60
Study 33760261 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc Blue (VDW)
Number of subjects: 60
Study 32599033 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination trials
Number of subjects: 278
Study 32599033 — intervention group
Group type: EXPERIMENTAL
Intervention: Industry-funded trials
Number of subjects: 278
Study 32599033 — intervention group
Group type: COMPARATOR
Intervention: US trials
Number of subjects: 278
Study 32599033 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall consent rate
Number of subjects: 278
Study 32599033 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials with consent rate <70%
Number of subjects: 278
Study 34518263 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronised purified flavonoid fraction (MPFF, Venixxa) 1000 mg orally for 6 months
Number of subjects: 86
Study 34518263 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar appearing) for 6 months
Number of subjects: 86
Study 34518263 — intervention group
Group type: EXPERIMENTAL
Intervention: MPFF
Number of subjects: 86
Study 34518263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 32924754 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline EQ-5D scores
Number of subjects: 13801
Study 32924754 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline VAS scores
Number of subjects: 13801
Study 32924754 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline peripheral artery questionnaire scores
Number of subjects: 13801
Study 32924754 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved EQ-5D scores over 12 months
Number of subjects: 13801
Study 32924754 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved VAS scores over 12 months
Number of subjects: 13801
Study 35180850 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis (PD)
Number of subjects: 66
Study 33765725 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous skin paste group
Number of subjects: 18
Study 33765725 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment group
Number of subjects: 18
Study 35421233 — intervention group
Group type: EXPERIMENTAL
Intervention: RRB (125 g fresh equivalents) daily
Number of subjects: 26
Study 35421233 — intervention group
Group type: EXPERIMENTAL
Intervention: RRB + FOS (8g) daily
Number of subjects: 26
Study 34918028 — intervention group
Group type: EXPERIMENTAL
Intervention: EFV1 (efavirenz with TB treatment containing rifapentine 1200mg, isoniazid, pyrazinamide, and either ethambutol or moxifloxacin)
Number of subjects: 111
Study 34918028 — intervention group
Group type: EXPERIMENTAL
Intervention: EFV2 (newly initiating efavirenz with TB treatment containing rifapentine 1200mg, isoniazid, pyrazinamide, and either ethambutol or moxifloxacin)
Number of subjects: 111
Study 36474181 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured supervised exercise training (EXE)
Number of subjects: 220
Study 36474181 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational counselling on PA (MOT)
Number of subjects: 220
Study 36474181 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 220
Study 33930612 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics + Fish Oil (FO)
Number of subjects: 439
Study 33930612 — intervention group
Group type: COMPARATOR
Intervention: Fish Oil + Placebo
Number of subjects: 439
Study 33930612 — intervention group
Group type: COMPARATOR
Intervention: Probiotics + Placebo
Number of subjects: 439
Study 32767506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei TH14 (105 cfu/kg FM) + cellulase (10,000 unit/kg FM) + molasses (50 g/kg FM)
Number of subjects: 0
Study 32767506 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulase (10,000 unit/kg FM) + molasses (50 g/kg FM)
Number of subjects: 0